New Depo-Provera Lawsuits Allege Link to Brain Tumors Pfizer’s contraceptive injectable drug Depo-Provera has come under intensified scrutiny after some studies have linked the pharmaceutical’s active ingredient medroxyprogesterone acetate, may increase the risk View Article October 1, 2024
